Emily Kaiser Maharjan, Assistant Managing Editor

Second annual meeting builds upon firm foundation to enhance education.

Welcome to the You and Eye podcast. We're kicking things off with a little bit of background on our host, Miriam Korik, OD. She chats about her journey as an optometrist and where she sees herself—and this podcast—going.

Andrew S. Morgenstern, OD, FAAO, FNAP sits down with Optometry Times to reiterate under-utilized diagnostic tools for keratoconus and the planning of this year's International Keratoconus Academy Keratoconus Symposium, running from May 18-19 in Bethesda, Maryland.

Diffusion Optics Technology (DOT) spectacle lenses are intended to slow myopia progression in children via contrast management mechanism of action.

Optometry Times chats with Michael Chaglasian, OD, FAAO during this year's Glaucoma 360 meeting in San Francisco, California.

OKYO Pharma announced the acceptance of OK-101 as an investigational new drug following clinical studies investigating the candidate in patients with neuropathic corneal pain, the first to do so.

Catch up on what happened in optometry during the week of February 5-February 9.

Cecelia Koetting, OD, FAAO, DIPABO chats with Optometry Times about her role with EnVision Summit's new optometry program and the excitement surrounding the event.

William Hogue, OD, MS, sat down with Optometry Times to outline what symptoms and risk factors eye care providers should look out for in identifying central serous chorioretinopathy in their patients, as well as what treatment options are available.

Catch up on what happened in optometry during the week of January 22-January 26.

Bonnie An Henderson, MD, cofounder of EnVision Summit, sits down with Optometry Times to detail the upcoming event that takes a unique, family-friendly approach to centering diversity in the eye care profession.

Catch up on what happened in optometry during the week of January 15-January 19.

The 2024 EnVision Summit will feature a brand-new Optometry Program, co-chaired by Danica Marrelli, OD, FAAO, AAO Dipl, and Cecelia Koetting, OD, FAAO, DipABO.

Robert Weiss, former president and CEO of The Cooper Companies, shares some of the latest optometric schooling developments from Vietnam in his work with Optometry Giving Sight, the Brian Holden Foundation, and Hanoi Medical University.

Catch up on what happened in optometry during the week of January 8-January 12.

Harrow’s Vevye is the first and only cyclosporine-based product approved for the treatment of both signs and symptoms of dry eye disease.

AR-15512 is a topical transient receptor potential melastatin 8 (TRPM8) agonist designed to treat the signs and symptoms of DED via increased tear production.

Catch up on what happened in optometry during the week of January 1-January 5.

Catch up on what happened in optometry during the week of December 25-December 29.

A report by Technavio indicates that lifestyle changes will increase eyewear sales across the globe.

From FDA approvals to innovations in lens tech, 2023 was a big year in eye care.

Catch up on what happened in optometry during the week of December 18-December 22.

Damon Dierker, OD, FAAO, shares latest updates in research on sutureless cryopreserved amniotic membrane for moderate-to-severe dry eye with short treatment duration.

Catch up on what happened in optometry during the week of December 11-December 15.

Eye care witnessed a transformative year with 11 FDA approvals. As the year concludes, there remains a robust pipeline of drugs, setting high expectations for continued advancements in ophthalmological care in 2024 and beyond.

A research report compiled by The Vision Council reveals that most parents are aware of myopia but remain in the dark about prevalence and how to prevent progression.

The multidisciplinary program aims to bring myopia management tools to under-resourced children across the US.

Catch up on what happened in optometry during the week of December 4-December 8.

Dr Mile Brujic discusses his EyeCon presentations, which spanned from antibody drug conjugates (ADCs) and their effect on ocular toxicity for patients with cancer to innovations in eye care.

Catch up on what happened in optometry during the week of November 27-December 1.